a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2490 clinical trials
Safety and Efficacy of C21 in Subjects With COVID-19

This is a randomised, double-blind, placebo-controlled phase 2 trial investigating the safety and efficacy of C21 in subjects who are hospitalised with COVID-19 infection, but not in need of mechanical invasive or non-invasive ventilation.

coronavirus infection
noninvasive ventilation
covid-19
PCR test
acute respiratory syndrome (sars)
  • 0 views
  • 16 Feb, 2024
  • 3 locations
Tactile Low Vision Labeling of Ophthalmic Drops

The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch (UTMB) in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)

Recent research suggest that reduced sitting and increased physical activity can be supported at a low cost by mHealth (mobile health) technology such as activity tracker armbands that warns of prolonged sitting and SMS text messages that reminds of activity breaks.

hba1c
  • 0 views
  • 16 Feb, 2024
  • 1 location
Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) single-center, single-arm study to evaluate the feasibility and safety of the combination of Scoring-Balloon (SCA-DEB)  

This is a prospective, single-center, single-arm study to evaluate the feasibility and safety of the combination of Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the treatment of diffuse, small vessel coronary artery disease.

  • 0 views
  • 02 Mar, 2026
  • 4 locations
Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening

This is a multi center two-stage, two-arm, open label phase II study of venetoclax in combination with azacytidine in acute myeloid leukemia patients selected for therapy with ex vivo venetoclax sensitivity screening.

acute promyelocytic leukemia
ejection fraction
acute myeloid leukemia
heart failure
cardiac disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location
Comparison of Virtual Reality to Tablet-based Distraction in Children

The proposed study is a prospective randomized trial to be performed in pediatric patient's ages 4 to 10 years undergoing surgical procedures requiring general anesthesia.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma

This is a prospective, open-labelled study to evaluate the efficacy and safety of camrelizumab combined with apatinib mesylate in the induction treatment of patients with locally advanced head and neck squamous cell carcinoma who were judged surgically unresectable or appropriate for non-surgical definitive therapy.

measurable disease
kidney function tests
locally advanced head and neck squamous cell carcinoma
cancer of the head
definitive treatment
  • 0 views
  • 16 Feb, 2024
  • 1 location
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

This is a Phase 1, multicenter, open-label, multiple-dose, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, and pharmacodynamics of TTX-080 monotherapy in subjects with advanced or metastatic solid tumors known to express HLA-G.

measurable disease
hla-g
cancer
metastasis
solid tumour
  • 0 views
  • 05 Aug, 2020
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

eRapa (encapsulated rapamycin) will be investigated for secondary prevention in patients with diagnosed non-muscle invasive bladder cancer (NMIBC) through a phase II double-blind randomized controlled trial of long-term (one year) prevention with eRapa versus placebo. The primary hypothesis is that eRapa decreases the risk of cancer relapse for patients with …

  • 2 views
  • 05 Aug, 2020
Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

., convalescent plasma) and if it is able to prevent disease or lessen the severity of disease in individuals who are at high risk of developing COVID-19 due to a recent exposure. This study will also measure the level of anti-SARS-CoV-2 antibodies in patient's blood after the administration of the …

respiratory failure
acute respiratory syndrome (sars)
pediatric
nasopharyngeal swab
SARS
  • 0 views
  • 05 Aug, 2020